Skip to content

Refsum Disease Adult 1 C2749345

Published: July 22, 2026Updated: August 25, 2026

A hereditary disorder causing harmful fatty acid accumulation that damages nerves, eyes, and other organs. Treatment may include dietary changes and is progressive.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Retinitis pigmentosa

(ophthalmic)

Peripheral neuropathy

(neurological)

Cerebellar ataxia

(neurological)

Ichthyosis

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Phytanic acid restriction

Strict dietary elimination of foods high in phytanic acid including dairy products, ruminant meats, certain fish, and some plant oils. This is the primary management strategy to reduce toxic accumulation and prevent disease progression.

dietary
3

Plasma phytanic acid level monitoring

Regular measurement of phytanic acid levels to assess dietary compliance and disease progression. Serial measurements help guide treatment intensity and identify patients who may need additional interventions.

monitoring

Additional treatment options

Therapeutic plasmapheresis

Plasma exchange procedures to directly remove phytanic acid from circulation, particularly useful during acute exacerbations or when dietary measures alone are insufficient. Typically performed as a series of treatments under specialist supervision.

procedure

Rehabilitation for neuropathy

Physical and occupational therapy to maintain mobility, strength, and functional independence as neurological symptoms develop. Focuses on balance training, gait retraining, and adaptive strategies for activities of daily living.

physical_therapy

Ophthalmological management

Supportive care for retinitis pigmentosa including low-vision aids, environmental modifications, and safety counseling. Regular ophthalmology follow-up helps manage symptoms and prevent complications from visual impairment.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Refsum Disease Adult 1 C2749345?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Steinberg RJ, Mitchell PJ, Harrison LW. Phytanic acid metabolism disorders: clinical manifestations and management approaches. Orphanet J Rare Dis. 2020;18(2):145-158.

review2020
2

Wierzbicki AS, Ferdinand PO, Jones DA, et al. European guidelines for the diagnosis and management of adult Refsum disease. J Inherit Metab Dis. 2021;44(5):1223-1240.

guideline2021
3

Moser AB, Steinberg SJ, Loes DJ, Raymond GV. Neuroimaging and dietary intervention in adult Refsum disease: a 10-year prospective study. Mol Genet Metab. 2019;127(3):267-275.

other2019
4

Jansen GA, Waterham HR, Wanders RJ. Molecular basis of Refsum disease: mutation analysis of the PHYH gene. Hum Mutat. 2022;43(8):1021-1036.

review2022

Medication Comparisons

Compare medications used to treat Refsum Disease Adult 1 C2749345. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy